4.7 Article

Second-Line Chemotherapy With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI Regimen) in Patients With Advanced Small Bowel Adenocarcinoma After Failure of First-Line Platinum-Based Chemotherapy A Multicenter AGEO Study

Related references

Note: Only part of the references are listed.
Article Oncology

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine

M. J. Overman et al.

BRITISH JOURNAL OF CANCER (2010)

Article Medicine, General & Internal

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

Eric Van Cutsem et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Oncology

Cancer statistics, 2008

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2008)

Article Oncology

Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: A retrospective review of 113 cases

Paula N. Fishman et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2006)

Article Medicine, General & Internal

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

D Cunningham et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, General & Internal

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

H Hurwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)